Further investigation demonstrated that calpain inhibition downregulated several pro-inflammatory cytokines (IL-17, IL-23, TNFα, G-CSF, IL-12) in MS PBMCs while it upregulated IDO expression and limited T cell proliferation, indicating that inhibition of calpain may ameliorate immune pathology in MS [119]. This evidence concerns the gene IL17A and myeloid sarcoma.